Search Results 2291-2300 of 14665 for anti-TNF drugs

1. Tirzepatide (Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Mounjaro; Zepbound. Descriptions. Tirzepatide injection is ...

2. Darunavir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

3. Phase ll Study of Pirfenidone in Patients With RAILD - Mayo Clinic

   Any use of an approved anti-fibrotic medication within 28 days of screening. Participating Mayo Clinic locations. Study statuses change often. Please contact ...

4. Daunorubicin Citrate Liposome (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

5. Coagulation Factor Viia-Jncw (Intravenous Route) Before Using - Mayo Clinic

   ... medicines. Anti-Inhibitor Coagulant Complex; Factor XIII; Prothrombin Complex. Other Interactions. Certain medicines should not be used at or around the time of ...

6. Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients - Mayo Clinic

   Prior therapy with pomalidomide. Any anti-myeloma drug treatment within 14 days before randomization, including dexamethasone. Eastern Cooperative Oncology ...

7. Lurbinectedin + Doxorubicin In Leiomyosarcoma - Mayo Clinic

   ... anti-epileptic medications. History of allergic reactions attributed to compounds of similar chemical or biologic composition to lurbinectedin or ...

8. Tarlatamab-Dlle (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

9. ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) - Mayo Clinic

   randomization. 8. Stable or decreasing dose of corticosteroids and anti-seizure medications for 7 days prior to randomization, if applicable. Stable steroid ...

10. Betamethasone And Calcipotriene (Topical Application Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...